Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: long-term follow up on IBCSG Trial IX
Options
BORIS DOI
Publisher DOI
PubMed ID
21282282
Description
The benefit of adjuvant chemotherapy in postmenopausal patients with estrogen receptor (ER)-positive lymph node-negative breast cancer is being reassessed.
Date of Publication
2011
Publication Type
Article
Language(s)
en
Contributor(s)
Aebi, S | |
Sun, Z | |
Braun, D | |
Price, K N | |
Castiglione-Gertsch, M | |
Gelber, R D | |
Crivellari, D | |
Lindtner, J | |
Snyder, R | |
Karlsson, P | |
Simoncini, E | |
Gusterson, B A | |
Viale, G | |
Regan, M M | |
Coates, A S | |
Goldhirsch, A |
Additional Credits
Series
Annals of oncology
Publisher
Oxford University Press
ISSN
0923-7534
Access(Rights)
open.access